Poisons on Pets: Health Hazards from Flea and Tick Products (Pdf)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
D-Phenothrin
United States Prevention, Pesticides Environmental Protection and Toxic Substances September 2008 Agency (7508P) Reregistration Eligibility Decision for d-Phenothrin September 2008 Reregistration Eligibility Decision for Phenothrin List A Case No. 0426 2 Glossary of Terms and Abbreviations ae Acid Equivalent ai Active Ingredient CFR Code of Federal Regulations CSF Confidential Statement of Formula DCI Data Call-In EDWC Estimated Drinking Water Concentration EEC Estimated Environmental Concentration EIIS Ecological Incident Information System EPA Environmental Protection Agency EUP End-Use Product FDA Food and Drug Administration FIFRA Federal Insecticide, Fungicide, and Rodenticide Act FFDCA Federal Food, Drug, and Cosmetic Act FQPA Food Quality Protection Act LC50 Median Lethal Concentration. A statistically derived concentration of a substance that can be expected to cause death in 50% of test animals. It is usually expressed as the weight of substance per weight or volume of water, air or feed, e.g., mg/l, mg/kg or ppm. LD50 Median Lethal Dose. A statistically derived single dose that can be expected to cause death in 50% of the test animals when administered by the route indicated (oral, dermal, inhalation). It is expressed as a weight of substance per unit weight of animal, e.g., mg/kg. LOC Level of Concern LOAEL Lowest Observed Adverse Effect Level mg/kg/day Milligram Per Kilogram Per Day mg/L Milligrams Per Liter MOE Margin of Exposure MRID Master Record Identification (number). EPA's system of recording and tracking studies submitted. -
Evaluation of Fluralaner and Afoxolaner Treatments to Control Flea
Dryden et al. Parasites & Vectors (2016) 9:365 DOI 10.1186/s13071-016-1654-7 RESEARCH Open Access Evaluation of fluralaner and afoxolaner treatments to control flea populations, reduce pruritus and minimize dermatologic lesions in naturally infested dogs in private residences in west central Florida USA Michael W. Dryden1*, Michael S. Canfield2, Kimberly Kalosy1, Amber Smith1, Lisa Crevoiserat1, Jennifer C. McGrady1, Kaitlin M. Foley1, Kathryn Green2, Chantelle Tebaldi2, Vicki Smith1, Tashina Bennett1, Kathleen Heaney3, Lisa Math3, Christine Royal3 and Fangshi Sun3 Abstract Background: A study was conducted to evaluate and compare the effectiveness of two different oral flea and tick products to control flea infestations, reduce pruritus and minimize dermatologic lesions over a 12 week period on naturally infested dogs in west central FL USA. Methods: Thirty-four dogs with natural flea infestations living in 17 homes were treated once with a fluralaner chew on study day 0. Another 27 dogs living in 17 different homes were treated orally with an afoxolaner chewable on day 0, once between days 28–30 and once again between days 54–60. All products were administered according to label directions by study investigators. Flea populations on pets were assessed using visual area counts and premise flea infestations were assessed using intermittent-light flea traps on days 0, 7, 14, 21, and once between days 28–30, 40–45, 54–60 and 82–86. Dermatologic assessments were conducted on day 0 and once monthly. Pruritus assessments were conducted by owners throughout the study. No concurrent treatments for existing skin disease (antibiotics, anti-inflammatories, anti-fungals) were allowed. -
Historical Perspectives on Apple Production: Fruit Tree Pest Management, Regulation and New Insecticidal Chemistries
Historical Perspectives on Apple Production: Fruit Tree Pest Management, Regulation and New Insecticidal Chemistries. Peter Jentsch Extension Associate Department of Entomology Cornell University's Hudson Valley Lab 3357 Rt. 9W; PO box 727 Highland, NY 12528 email: [email protected] Phone 845-691-7151 Mobile: 845-417-7465 http://www.nysaes.cornell.edu/ent/faculty/jentsch/ 2 Historical Perspectives on Fruit Production: Fruit Tree Pest Management, Regulation and New Chemistries. by Peter Jentsch I. Historical Use of Pesticides in Apple Production Overview of Apple Production and Pest Management Prior to 1940 Synthetic Pesticide Development and Use II. Influences Changing the Pest Management Profile in Apple Production Chemical Residues in Early Insect Management Historical Chemical Regulation Recent Regulation Developments Changing Pest Management Food Quality Protection Act of 1996 The Science Behind The Methodology Pesticide Revisions – Requirements For New Registrations III. Resistance of Insect Pests to Insecticides Resistance Pest Management Strategies IV. Reduced Risk Chemistries: New Modes of Action and the Insecticide Treadmill Fermentation Microbial Products Bt’s, Abamectins, Spinosads Juvenile Hormone Analogs Formamidines, Juvenile Hormone Analogs And Mimics Insect Growth Regulators Azadirachtin, Thiadiazine Neonicotinyls Major Reduced Risk Materials: Carboxamides, Carboxylic Acid Esters, Granulosis Viruses, Diphenyloxazolines, Insecticidal Soaps, Benzoyl Urea Growth Regulators, Tetronic Acids, Oxadiazenes , Particle Films, Phenoxypyrazoles, Pyridazinones, Spinosads, Tetrazines , Organotins, Quinolines. 3 I Historical Use of Pesticides in Apple Production Overview of Apple Production and Pest Management Prior to 1940 The apple has a rather ominous origin. Its inception is framed in the biblical text regarding the genesis of mankind. The backdrop appears to be the turbulent setting of what many scholars believe to be present day Iraq. -
Federal Register/Vol. 86, No. 161/Tuesday, August 24, 2021
Federal Register / Vol. 86, No. 161 / Tuesday, August 24, 2021 / Rules and Regulations 47221 EPA–APPROVED MISSOURI REGULATIONS State effective Missouri citation Title date EPA approval date Explanation Missouri Department of Natural Resources ******* Chapter 6—Air Quality Standards, Definitions, Sampling and Reference Methods, and Air Pollution Control Regulations for the State of Missouri ******* 10–6.110 ........... Reporting Emission Data, Emis- 3/30/2021 8/24/2021, [Insert Federal Reg- Section (3)(A), Emission Fees, sion Fees, and Process Infor- ister citation]. has not been approved as part mation. of the SIP. ******* * * * * * ACTION: Final rule. year. To the maximum extent prudent and determinable, we must designate PART 70—STATE OPERATING PERMIT SUMMARY: We, the U.S. Fish and critical habitat for any species that we PROGRAMS Wildlife Service (Service), are listing the determine to be an endangered or Franklin’s bumble bee (Bombus threatened species under the Act. ■ 3. The authority citation for part 70 franklini), an invertebrate species from Listing a species as an endangered or continues to read as follows: Douglas, Jackson, and Josephine threatened species and designation of Authority: 42 U.S.C. 7401, et seq. Counties in Oregon, and Siskiyou and critical habitat can only be completed Trinity Counties in California, as an ■ 4. In appendix A to part 70 the entry by issuing a rule. endangered species under the What this document does. This rule for ‘‘Missouri’’ is amended by adding Endangered Species Act of 1973, as paragraph (jj) to read as follows: lists Franklin’s bumble bee (Bombus amended (Act). This rule adds this franklini) as an endangered species Appendix A to Part 70—Approval species to the Federal List of under the Act. -
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig. -
Neonicotinoid Insecticide Hydrolysis and Photolysis: Rates and Residual Toxicity
Neonicotinoid Insecticide Hydrolysis and Photolysis: Rates and Residual Toxicity A THESIS SUBMITTED TO THE FACULTY OF THE UNIVERSITY OF MINNESOTA BY Stephen Anthony Todey IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE William Arnold May 2018 © Stephen Todey, 2018 ii Acknowledgements I would like to thank Bill for all his help and guidance throughout this project, and Ann Fallon, who completed all the parent and product toxicity experiments. Thank you to Xun Ming at the Masonic Cancer Center (University of Minnesota – Twin Cities) who helped to develop the UPLC – MS/MS method used for this research and helped to operate the Orbitrap Velos. Thanks to undergraduates Josh and Amit for the work they helped to complete in the lab, and for all the dishes they washed. Thank you to all the members of the Arnold Lab Group for making me feel welcome and helping me throughout the process of completing my masters. Extra special thanks to Jill Kerrigan, Andrew McCabe, and Sarah Pati for their guidance in experimental design and data analysis. Finally, thank you to my parents, Francis and Marianne Todey, and Jennifer Anderson. I would not have gone this far without your help and support. Funding for this project was provided by the Legislative-Citizen Commission on Minnesota Resources (LCCMR). i Abstract Neonicotinoid insecticides are currently the most widely used class of insecticides worldwide, accounting for 25% of total insecticide use. They are registered in 120 countries for use on more than 140 crops. Concern has grown, however, over their widespread detection in global surface waters, soil, finished drinking water, and wastewater, and for their potential role in colony collapse disorder in honey bees. -
When Endocrine Abnormalities Are a Medication Side Effect
When Endocrine Abnormalities are a Medication Side Effect Donald Beckstead, MD T. Grant Phillips, MD Michael Geishauser, PharmD UPMC Altoona Family Physicians 1 DISCLOSURES • Sadly, we have nothing to disclose 2 OBJECTIVES • Identify commonly used drugs that may cause new endocrine abnormalities • Discuss mechanisms for development of such abnormalities • Touch on risk factors for the development of some medication induced endocrine abnormalities • Mention principles to guide work‐up and treatment 3 THYROID AND DRUGS 4 Amiodarone • Can cause hyper‐ or hypothyroidism • One amiodarone molecule contains two atoms of iodine • Amiodarone has 75 mg iodine/tablet • 6 mg released into circulation • WHO recommendation 150 mcg/day I2 5 Amiodarone • Clinically significant thyroid dysfunction occurs 5‐15% • Risk factors for hypothyroidism: – Female – Positive thyroid antibody – Residence in an iodine‐repleted region • Thyrotoxicosis 2‐12% – Risk factors: male, iodine deficient region 6 Amiodarone • Iodine deficient: Hyperthyroid • Iodine excess: Hypothyroid 7 Lithium • Once used as an antithyroid drug • 1‐3% people develop goiter • May precipitate undiagnosed autoimmune thyroid disorders • Can block thyroid hormone release from thyroglobulin 8 PPIs • Raise gastric pH • Certain level of stomach acid necessary for ingestion of thyroxine (dissolve pills) • TSH increased with PPI treatment • Reduce absorption by reducing dissolution of pills • Liquid formulation may solve problem 9 Miscellaneous Drugs • Thyroid hormone is actively oxidized and conjugated -
NINDS Custom Collection II
ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC -
Mitochondrial Toxicity of Triclosan on Mammalian Cells
Toxicology Reports 2 (2015) 624–637 Contents lists available at ScienceDirect Toxicology Reports j ournal homepage: www.elsevier.com/locate/toxrep Mitochondrial toxicity of triclosan on mammalian cells a,∗,1 a,1 b,1 c Charmaine Ajao , Maria A. Andersson , Vera V. Teplova , Szabolcs Nagy , d e f g Carl G. Gahmberg , Leif C. Andersson , Maria Hautaniemi , Balazs Kakasi , h a Merja Roivainen , Mirja Salkinoja-Salonen a Department of Food and Environmental Sciences, Haartman Institute, University of Helsinki, POB 56, FI-00014, Finland b Institute of Theoretical and Experimental Biophysics, RAS, Puschino, Moscow Region, Russia c Department of Animal Science and Animal Husbandry, University of Pannonia, Georgikon Faculty, Deak F. u.,16, H8360 Keszthely, Hungary d Dept. of Bio- and Environmental Sciences, Haartman Institute, University of Helsinki, FI-00014, Finland e Dept. of Pathology, Haartman Institute, University of Helsinki, FI-00014, Finland f Finnish Food Safety Authority (EVIRA), Research and Laboratory Department, Veterinary Virology Research Unit, Mustialankatu 3, FI 00790 Helsinki, Finland g Institute of Environmental Sciences, University of Pannonia, Egyetem u. 10, H-8200 Veszprem, Hungary h National Institute for Health and Welfare, Department of Virology, Mannerheimintie 166, 00300 Helsinki, Finland a r t a b i c s t l r e i n f o a c t Article history: Effects of triclosan (5-chloro-2 -(2,4-dichlorophenoxy)phenol) on mammalian cells were Received 28 January 2015 investigated using human peripheral blood mono nuclear cells (PBMC), keratinocytes Received in revised form 29 March 2015 (HaCaT), porcine spermatozoa and kidney tubular epithelial cells (PK-15), murine pan- Accepted 30 March 2015 creatic islets (MIN-6) and neuroblastoma cells (MNA) as targets. -
Toxicity, Sublethal and Low Dose Effects of Imidacloprid and Deltamethrin on the Aphidophagous Predator Ceratomegilla Undecimnotata (Coleoptera: Coccinellidae)
insects Article Toxicity, Sublethal and Low Dose Effects of Imidacloprid and Deltamethrin on the Aphidophagous Predator Ceratomegilla undecimnotata (Coleoptera: Coccinellidae) Panagiotis J. Skouras 1,* , Anastasios I. Darras 2 , Marina Mprokaki 1, Vasilios Demopoulos 3, John T. Margaritopoulos 4 , Costas Delis 2 and George J. Stathas 1 1 Laboratory of Agricultural Entomology and Zoology, Department of Agriculture, Kalamata Campus, University of the Peloponnese, 24100 Antikalamos, Greece; [email protected] (M.M.); [email protected] (G.J.S.) 2 Department of Agriculture, Kalamata Campus, University of the Peloponnese, 24100 Antikalamos, Greece; [email protected] (A.I.D.); [email protected] (C.D.) 3 Laboratory of Plant Protection, Department of Agriculture, Kalamata Campus, University of the Peloponnese, 24100 Antikalamos, Greece; [email protected] 4 Department of Plant Protection, Institute of Industrial and Fodder Crops, Hellenic Agricultural Organization “DEMETER”—NAGREF, 38446 Volos, Greece; [email protected] * Correspondence: [email protected]; Tel.: +30-27210-45277 Simple Summary: Chemical insecticides are used to control agricultural pests all over the world. However, extensive use of chemical insecticides can be harmful to human health and negatively Citation: Skouras, P.J.; Darras, A.I.; impact the environment and biological control agents. We studied the toxicity and sublethal effects Mprokaki, M.; Demopoulos, V.; of imidacloprid and deltamethrin on the aphidophagous coccinellid predator Ceratomegilla -
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
USOO6264,917B1 (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness et al. (45) Date of Patent: Jul. 24, 2001 (54) TARGETED ULTRASOUND CONTRAST 5,733,572 3/1998 Unger et al.. AGENTS 5,780,010 7/1998 Lanza et al. 5,846,517 12/1998 Unger .................................. 424/9.52 (75) Inventors: Jo Klaveness; Pál Rongved; Dagfinn 5,849,727 12/1998 Porter et al. ......................... 514/156 Lovhaug, all of Oslo (NO) 5,910,300 6/1999 Tournier et al. .................... 424/9.34 FOREIGN PATENT DOCUMENTS (73) Assignee: Nycomed Imaging AS, Oslo (NO) 2 145 SOS 4/1994 (CA). (*) Notice: Subject to any disclaimer, the term of this 19 626 530 1/1998 (DE). patent is extended or adjusted under 35 O 727 225 8/1996 (EP). U.S.C. 154(b) by 0 days. WO91/15244 10/1991 (WO). WO 93/20802 10/1993 (WO). WO 94/07539 4/1994 (WO). (21) Appl. No.: 08/958,993 WO 94/28873 12/1994 (WO). WO 94/28874 12/1994 (WO). (22) Filed: Oct. 28, 1997 WO95/03356 2/1995 (WO). WO95/03357 2/1995 (WO). Related U.S. Application Data WO95/07072 3/1995 (WO). (60) Provisional application No. 60/049.264, filed on Jun. 7, WO95/15118 6/1995 (WO). 1997, provisional application No. 60/049,265, filed on Jun. WO 96/39149 12/1996 (WO). 7, 1997, and provisional application No. 60/049.268, filed WO 96/40277 12/1996 (WO). on Jun. 7, 1997. WO 96/40285 12/1996 (WO). (30) Foreign Application Priority Data WO 96/41647 12/1996 (WO). -
Lifetime Organophosphorous Insecticide Use Among Private Pesticide Applicators in the Agricultural Health Study
Journal of Exposure Science and Environmental Epidemiology (2012) 22, 584 -- 592 & 2012 Nature America, Inc. All rights reserved 1559-0631/12 www.nature.com/jes ORIGINAL ARTICLE Lifetime organophosphorous insecticide use among private pesticide applicators in the Agricultural Health Study Jane A. Hoppin1, Stuart Long2, David M. Umbach3, Jay H. Lubin4, Sarah E. Starks5, Fred Gerr5, Kent Thomas6, Cynthia J. Hines7, Scott Weichenthal8, Freya Kamel1, Stella Koutros9, Michael Alavanja9, Laura E. Beane Freeman9 and Dale P. Sandler1 Organophosphorous insecticides (OPs) are the most commonly used insecticides in US agriculture, but little information is available regarding specific OP use by individual farmers. We describe OP use for licensed private pesticide applicators from Iowa and North Carolina in the Agricultural Health Study (AHS) using lifetime pesticide use data from 701 randomly selected male participants collected at three time periods. Of 27 OPs studied, 20 were used by 41%. Overall, 95% had ever applied at least one OP. The median number of different OPs used was 4 (maximum ¼ 13). Malathion was the most commonly used OP (74%) followed by chlorpyrifos (54%). OP use declined over time. At the first interview (1993--1997), 68% of participants had applied OPs in the past year; by the last interview (2005--2007), only 42% had. Similarly, median annual application days of OPs declined from 13.5 to 6 days. Although OP use was common, the specific OPs used varied by state, time period, and individual. Much of the variability in OP use was associated with the choice of OP, rather than the frequency or duration of application.